Posted in M&A / Deals Oricell closes a ‘pre-IPO’ megaround to aim CAR-T at solid tumors April 10, 2026 BioPharma Dive The Shanghai-based biotech has a cell therapy that, if successful in testing, could become the first treatment of its kind for liver cancer. M&A / DealsOncologyRead full story